CY1125270T1 - Βελτιωσεις σε και σχετιζομενες με συνθεσεις - Google Patents

Βελτιωσεις σε και σχετιζομενες με συνθεσεις

Info

Publication number
CY1125270T1
CY1125270T1 CY20221100327T CY221100327T CY1125270T1 CY 1125270 T1 CY1125270 T1 CY 1125270T1 CY 20221100327 T CY20221100327 T CY 20221100327T CY 221100327 T CY221100327 T CY 221100327T CY 1125270 T1 CY1125270 T1 CY 1125270T1
Authority
CY
Cyprus
Prior art keywords
preserved
solutions
compositions
constipation
electrolytes
Prior art date
Application number
CY20221100327T
Other languages
Greek (el)
English (en)
Original Assignee
Norgine Healthcare B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1101666.4A external-priority patent/GB201101666D0/en
Priority claimed from GBGB1101738.1A external-priority patent/GB201101738D0/en
Priority claimed from GBGB1200637.5A external-priority patent/GB201200637D0/en
Application filed by Norgine Healthcare B.V. filed Critical Norgine Healthcare B.V.
Publication of CY1125270T1 publication Critical patent/CY1125270T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
CY20221100327T 2011-01-31 2022-05-11 Βελτιωσεις σε και σχετιζομενες με συνθεσεις CY1125270T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1101666.4A GB201101666D0 (en) 2011-01-31 2011-01-31 Improvements in and relating to compositions
GBGB1101738.1A GB201101738D0 (en) 2011-02-01 2011-02-01 Improvements in and relating to compositions
GBGB1200637.5A GB201200637D0 (en) 2012-01-13 2012-01-13 Improvements in and relating to compositions

Publications (1)

Publication Number Publication Date
CY1125270T1 true CY1125270T1 (el) 2024-12-13

Family

ID=45563438

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20221100327T CY1125270T1 (el) 2011-01-31 2022-05-11 Βελτιωσεις σε και σχετιζομενες με συνθεσεις

Country Status (17)

Country Link
EP (2) EP2862566B1 (cg-RX-API-DMAC10.html)
JP (2) JP2014504628A (cg-RX-API-DMAC10.html)
KR (1) KR101852502B1 (cg-RX-API-DMAC10.html)
CN (2) CN103458874A (cg-RX-API-DMAC10.html)
AU (1) AU2012213180B2 (cg-RX-API-DMAC10.html)
BR (1) BR112013019418B1 (cg-RX-API-DMAC10.html)
CY (1) CY1125270T1 (cg-RX-API-DMAC10.html)
DE (1) DE202012013349U1 (cg-RX-API-DMAC10.html)
DK (1) DK2862566T3 (cg-RX-API-DMAC10.html)
EA (1) EA028925B1 (cg-RX-API-DMAC10.html)
ES (1) ES2914034T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20220691T1 (cg-RX-API-DMAC10.html)
MX (1) MX360450B (cg-RX-API-DMAC10.html)
PL (1) PL2862566T3 (cg-RX-API-DMAC10.html)
PT (1) PT2862566T (cg-RX-API-DMAC10.html)
WO (1) WO2012104617A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201305342B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
BR112015005270B1 (pt) 2012-09-11 2022-11-01 Norgine Bv Composição para mistura com água, solução de limpeza de cólon, seus usos e seu kit
EA034234B1 (ru) 2013-03-15 2020-01-20 Брейнтри Лабораторис, Инк. Пероральные фармацевтические таблетированные композиции двойного применения, содержащие сульфат натрия или его комбинацию с другими сульфатными солями, и способы их получения и применения
WO2016208781A1 (ko) * 2015-06-22 2016-12-29 주식회사 씨티씨바이오 장관 세척용 하제 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002335900A1 (en) * 2001-10-29 2003-05-12 Shimizu Pharmaceutical Co., Ltd. Bowel cleansing agent
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
AU2006244112B2 (en) * 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
GB0912487D0 (en) * 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions

Also Published As

Publication number Publication date
ZA201305342B (en) 2014-12-23
BR112013019418A2 (cg-RX-API-DMAC10.html) 2017-08-29
EA028925B1 (ru) 2018-01-31
AU2012213180B2 (en) 2017-04-13
JP2018035181A (ja) 2018-03-08
CN103458874A (zh) 2013-12-18
BR112013019418B1 (pt) 2022-03-29
EA201300882A1 (ru) 2014-01-30
KR101852502B1 (ko) 2018-04-26
DK2862566T3 (da) 2022-05-16
EP2670391A1 (en) 2013-12-11
ES2914034T3 (es) 2022-06-07
WO2012104617A1 (en) 2012-08-09
MX360450B (es) 2018-11-01
PL2862566T3 (pl) 2022-06-20
EP2862566B1 (en) 2022-03-09
MX2013008635A (es) 2013-11-04
JP2014504628A (ja) 2014-02-24
EP2862566A1 (en) 2015-04-22
CN107260661A (zh) 2017-10-20
NZ613401A (en) 2016-03-31
DE202012013349U1 (de) 2016-06-27
HRP20220691T1 (hr) 2022-07-08
JP6498250B2 (ja) 2019-04-10
PT2862566T (pt) 2022-06-02
KR20140007881A (ko) 2014-01-20

Similar Documents

Publication Publication Date Title
GT201200322A (es) Derivados de carbamato de hexafluoroisoprofilo, su preparacion y su aplicacion en terapeutica
MA33939B1 (fr) 5-alcynyl-pyrimidines
EA201390347A1 (ru) Лечение заболеваний
CL2015000829A1 (es) Inhibidores de histona desmetilasas
MX2020005498A (es) Inhibidores de cdk.
UA110612C2 (uk) Похідні 1-аміно-2-циклопропілетилборонової кислоти
MA37400A1 (fr) Composés hétérocyclyle en tant qu'inhibiteurs de mek
CO6670585A2 (es) Promotores de apotosis n-acilsufonamidas
CY1120438T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει μυο-ινοσιτολη και d-κιρο-ινοσιτολη
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
UA113541C2 (xx) Заміщені піролідин-2-карбоксаміди
CL2012003075A1 (es) Composicion farmaceutica en solucion de pazopanib, estable y para uso oftalmico; metodo para la preparacion de dicha solucion.
EA201390799A1 (ru) Триазолопиридины
CY1116186T1 (el) Μακροκυκλικες ενωσεις και μεθοδοι για την παραγωγη τους
MX2013004061A (es) Analogos de ciclosporina.
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
EA201490599A1 (ru) Соединения триазолопиридина в качестве ингибиторов фосфодиэстеразы pde10a
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
MX2013004062A (es) Analogos de ciclosporina.
EA201590347A1 (ru) Азагетероциклы в качестве ингибиторов bir2 и/или bir3
EA201390925A1 (ru) Производные санглиферина и способы их получения
EA201390757A1 (ru) БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПРОИЗВОДСТВА
MX360450B (es) Mejoras de y relacionadas con composiciones.